HALEY KNOWLES: Open Payments
NPI 1083205199 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 20 payments from 12 companies in 2025. Trend: 2023 $806 · 2024 $4,049 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 3 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $142 |
| Abbott Laboratories | 1 | $126 |
| E.R. Squibb & Sons, L.L.C. | 5 | $88 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Imperative Care, Inc | 2 | $44 |
| Kestra Medical Technology Services, Inc. | 1 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $34 |
| Baxter Healthcare | 1 | $30 |
| ABIOMED | 1 | $29 |
Products named: FUROSCIX, Kerendia, CARDIOMEMS, ELIQUIS, LEQVIO, SYMPHONY CATHETER, Assure WCD, CAMZYOS.
Industry payments across TX — which companies pay providers there.
